scispace - formally typeset
P

Pedro Contreras

Researcher at University of Warwick

Publications -  32
Citations -  1327

Pedro Contreras is an academic researcher from University of Warwick. The author has contributed to research in topics: Hierarchical clustering & Cluster analysis. The author has an hindex of 9, co-authored 30 publications receiving 897 citations. Previous affiliations of Pedro Contreras include University of London & Royal Holloway, University of London.

Papers
More filters
Journal ArticleDOI

Algorithms for hierarchical clustering: an overview

TL;DR: A recently developed very efficient (linear time) hierarchical clustering algorithm is described, which can also be viewed as a hierarchical grid‐based algorithm.
Posted Content

Methods of Hierarchical Clustering

TL;DR: A recently developed very efficient (linear time) hierarchical clustering algorithm is described, which can also be viewed as a hierarchical grid-based algorithm.
Journal ArticleDOI

Hierarchical Clustering of Massive, High Dimensional Data Sets by Exploiting Ultrametric Embedding

TL;DR: This work derives a hierarchical clustering from relationships between sets of observations, rather than the traditional use of relationships between the observations themselves, and uses embedding in a Baire space, or longest common prefix ultrametric space, to compare this second approach to k-means.
Journal ArticleDOI

Fast, Linear Time Hierarchical Clustering using the Baire Metric

TL;DR: The Baire metric induces an ultrametric on a dataset and is of linear computational complexity, contrasted with the standard quadratic time agglomerative hierarchical clustering algorithm, and this work evaluates empirically this new approach to hierarchical clustered.
Journal ArticleDOI

Immunological markers of disease progression in patients infected with the human immunodeficiency virus.

TL;DR: Monitoring both total lymphocytes and beta 2-microglobulin identified 91% of the AIDS patients; these assays may allow reductions in the annual number of CD4(+)-cell evaluations and the costs associated with monitoring the immune status of HIV-positive patients.